Literature DB >> 17390038

Immunoexpression of lactoferrin in human sporadic renal cell carcinomas.

Giuseppe Giuffrè1, Valeria Barresi, Christodoulos Skliros, Gaetano Barresi, Giovanni Tuccari.   

Abstract

By immunohistochemistry, lactoferrin (Lf) expression was retrospectively investigated in 40 formalin-fixed paraffin-embedded kidney samples, obtained at surgery from an equal number of patients. Histologically, 28 cases were clear cell carcinomas (CCC), 7 papillary carcinomas (PC) and 5 chromophobe carcinomas (CC). Ten specimens of unaffected renal parenchyma were utilized as tissue control. On 4-microm thick sections, the Lf immunoreactivity was revealed either by a rabbit polyclonal or mouse monoclonal anti-human Lf antisera; the quantification of Lf immunoreactivity was performed using an intensity-distribution (ID) score. A positive immunoreaction by both anti-Lf antibodies was found in 62.5% (25/40) of RCC, mainly evident and diffuse by monoclonal antiserum. The immunoreactivity was observed in the cytoplasmic boundary of neoplastic cells in CCC and PC, while in CC Lf showed a diffuse granular cytoplasmic localization. Moreover, significant differences in Lf ID score were found among CCC and non-CCC variants (P<0.00001), the former showed a lower score; no relationships between immunohistochemical data and the sex or age of patients, grade of RCC, stage of the disease or degree of terminal anemia were encountered. Normal unaffected tubular structures were positive for Lf; glomeruli were unstained. The reduced Lf immunoexpression in some CCC may be because of the down-regulation of Lf gene due to the frequent deletion of 3p regions reported in this RCC variant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390038

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms?

Authors:  Antonio Ieni; Valeria Barresi; Maddalena Grosso; Giuseppe Speciale; Michele A Rosa; Giovanni Tuccari
Journal:  Pathol Oncol Res       Date:  2010-10-24       Impact factor: 3.201

2.  Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma.

Authors:  Amjad Shalabi; Zaid Abassi; Hoda Awad; Sarel Halachmi; Boaz Moskovitz; Yoram Kluger; Ofer Nativ
Journal:  World J Urol       Date:  2013-02-22       Impact factor: 4.226

3.  Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup.

Authors:  Antonio Ieni; Valeria Barresi; Luana Licata; Roberta Cardia; Carmine Fazzari; Giuseppe Nuciforo; Francesco Caruso; Michele Caruso; Vincenzo Adamo; Giovanni Tuccari
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

4.  Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma.

Authors:  Lihua Ni; Cheng Yuan; Changjiang Zhang; Yuandi Xiang; Juan Wu; Xiaolong Wang; Xiaoyan Wu
Journal:  Onco Targets Ther       Date:  2020-07-17       Impact factor: 4.147

5.  Lactoferrin immuno-expression in human normal and neoplastic bone tissue.

Authors:  Antonio Ieni; Valeria Barresi; Maddalena Grosso; Michele Attilio Rosa; Giovanni Tuccari
Journal:  J Bone Miner Metab       Date:  2009-02-26       Impact factor: 2.626

6.  Lactoferrin Isolation Using Monolithic Column Coupled with Spectrometric or Micro-Amperometric Detector.

Authors:  Vojtech Adam; Ondrej Zitka; Petr Dolezal; Ladislav Zeman; Ales Horna; Jaromir Hubalek; Jan Sileny; Sona Krizkova; Libuse Trnkova; Rene Kizek
Journal:  Sensors (Basel)       Date:  2008-01-24       Impact factor: 3.576

7.  Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas.

Authors:  A Ieni; V Barresi; G Branca; G Giuffrè; M A Rosa; G Tuccari
Journal:  Oncol Lett       Date:  2013-03-05       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.